There were some noteworthy developments this year in targeted therapies for hormone receptor-positive breast cancer.
Findings from the TAILORx clinical trial will help personalize treatment decisions for many patients with early stage breast cancer.
Researchers are working on ways to make immune system therapies more effective for more cancer patients.
Cancer research stories worth following this winter included reports on new approaches to immunotherapy currently being tested in clinical trials.
Recent cancer research stories worth following include a study on post-traumatic stress disorder after a cancer diagnosis.
Two FDA approvals for immunotherapy treatments highlight cancer research news this summer. But the extremely high costs of new cancer therapies are yet to be addressed.
New clinical trials will test whether the addition of progesterone could improve treatment for hormone receptor-positive breast cancer.
Cancer research stories worth following this spring include a study on the benefits of one type of immune system therapy for patients with metastatic triple negative breast cancer.
Cancer research stories worth following this winter include a possible new use for an existing drug to prevent metastasis in triple negative breast cancer.
Cancer research stories worth following this fall include new developments in targeted treatment for ovarian cancer and for metastatic breast cancer.